XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients

Escaping antitumor immunity is a hallmark in cancer progression. Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor responsible for the maintenance of immune tolerance; PD-1 ligand (PD-L1) is overexpressed in tumor cells, simplifying their escape from the immune system through T...

Descripción completa

Detalles Bibliográficos
Autores principales: Salama, Esraa A., Adbeltawab, Reda E., El Tayebi, Hend M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966712/
https://www.ncbi.nlm.nih.gov/pubmed/31998636
http://dx.doi.org/10.3389/fonc.2019.01459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966712/
https://www.ncbi.nlm.nih.gov/pubmed/31998636
http://dx.doi.org/10.3389/fonc.2019.01459

Ejemplares similares